
Regeneron Pharmaceuticals, Inc. (REGN) – A diversified growth story
The company is experiencing high demand for REGEN COV, its COVID 19 therapy. The therapy, REGEN COV, have been authorized in the United States...
The company is experiencing high demand for REGEN COV, its COVID 19 therapy. The therapy, REGEN COV, have been authorized in the United States...
The Conditional Marketing Authorization (CMA) for Spikevax ™ Moderna’s COVID 19 Vaccine) in the European Union (EU) and authorization in Japan by the Ministry...
Vertex anticipates that the number of CF patients treated with medicines will continue to grow as the company enter into additional reimbursement agreements, achieve...
The core competencies and resources developed over the last decade by the company has helped in development of first approved mRNA vaccine against COVID...
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple...
Outside of vaccines, the company have seven clinical proof of concept trials ongoing across four modalities. Its VEGF program partnered with AstraZeneca is enrolling...
Boutique research firm providing Business, Investment and M&A research services focused on fast growing Technology, Healthcare, Life science and Industrial sectors.
George Thangaiah Complex,
13, 80 Feet Rd, Near Sir CV Raman Hospital,
Indiranagar, Bengaluru, Karnataka – 560038
Ph: +91-9916444778